Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
OBJECTIVE:Patients with CAD have substantial residual risk of mortality, and whether hitherto unknown small-molecule metabolites and metabolic pathways contribute to this risk is unclear. We sought to determine the predictive value of plasma metabolomic profiling in patients with CAD. APPROACH AND R...
Main Authors: | Anurag Mehta, Chang Liu, Aditi Nayak, Ayman S Tahhan, Yi-An Ko, Devinder S Dhindsa, Jeong Hwan Kim, Salim S Hayek, Laurence S Sperling, Puja K Mehta, Yan V Sun, Karan Uppal, Dean P Jones, Arshed A Quyyumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0237579 |
Similar Items
-
Untargeted metabolomics reveal dysregulations in sugar, methionine, and tyrosine pathways in the prodromal state of AD
by: Ihab Hajjar, et al.
Published: (2020-01-01) -
Methodology Development and Application of Untargeted Metabolomics
by: Ching Lo, et al.
Published: (2019) -
Untargeted Metabolomic Characterization of Ovarian Tumors
by: Xiaona Liu, et al.
Published: (2020-12-01) -
MetabNet: an R package for metabolic association analysis of high-resolution metabolomics data
by: Karan eUppal, et al.
Published: (2015-06-01) -
Variable Selection in Untargeted Metabolomics and the Danger of Sparsity
by: Gerjen H. Tinnevelt, et al.
Published: (2020-11-01)